CIBC Bancorp USA »

Editas Medicine shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2026-03-31 $30k 12k 2.47

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Astrazeneca Ord (AZN)
Eli Lilly & Co. (LLY)
Flutter Entmt SHS (FLUT)
Vanguard Index Fds Mid Cap Etf (VO)
Exxon Mobil Corporation (XOM)

View all positions for CIBC Bancorp USA

Top funds holding Editas Medicine

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
Renaissance Technologies
Geode Capital Management
Nuveen
State Street Corporation
D. E. Shaw & Co
Opaleye Management
Two Sigma Investments
Acadian Asset Management
AQR Capital Management
Raymond James Financial
Kennedy Capital Management

View all funds holding Editas Medicine